References 1. Factsheet - World AIDS Day 2018. Geneva: UNAIDS; 2018. 2. Auvert B, Taljaard D, Lagarde E, et al. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2(11):e298.
for HIV prevention – July 2018. Geneva: WHO; 2018. 8. http://www.unaids.org/en/regionscountries/countries 9. Djimeu Wouabe E (2013). Scoping report on interventions for
3. Bailey C, Moses S, Parker CB, et al. (2007). Male circumcision
increasing the demand for voluntary medical male circumcision.
for HIV prevention in young men in Kisumu, Kenya: a
Washington, DC: International Initiative for Impact Evaluation.
randomized controlled trial. Lancet. 369:643–56.
10. Hatzold K, Chatora K, Taruberekera N, et al. (2017). Case
4. Gray H, Kigozi G, Serwadda D, et al. (2007). Male
study: Evidence-based demand creation and advocacy
circumcision for HIV prevention in young men in Rakai,
interventions for voluntary medical male circumcision scale-up
Uganda: a randomized trial. Lancet. 369:657–66.
in Zimbabwe. In: Social Marketing and Public Health: Theory
5. WHO/UNAIDS technical consultation on male circumcision
and Practice; 2nd ed. Oxford, UK: Oxford University Press.
and HIV prevention: research implications for policy and
11. Hatzold K, Mavhu W, Jasi P, et al. (2014). Barriers and
programming. Geneva: World Health Organization; 2007.
motivators to voluntary medical male circumcision uptake
6. Njeuhmeli E, Forsythe S, Reed J, et al. (2011). Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 8:e1001132. doi:10.1371/journal.pmed.1001132.
68
7. WHO progress brief: voluntary medical male circumcision
REFERENCES
among different age groups of men in Zimbabwe: results from a mixed methods study, PLoS ONE, 9 (4): e85051.
